Global | |
---|---|
n = 116 | |
n (%), mean (SD) or median [p25;p75] | |
Sociodemographic data | |
Sex, female | 64 (55.2%) |
Age, years | 76.0 [72.0;80.0] |
BMI, kg·m−2 | 27.7 [25.3;30.2] |
Education, years | 7.0 [7.0;7.0] |
Comorbidities | |
Hypertension | 73 (62.9%) |
Diabetes mellitus | 23 (19.8%) |
Cardiopathy | 25 (21.6%) |
Depression | 30 (25.9%) |
Periodic limb movements | 46 (44.7%) |
Alzheimer’s disease parameters | |
Cognitive function | |
MMSE | 23.0 [22.0;25.0] |
Biomarkers levels | |
Aβ42, pg/ml | 527 [415;643] |
T-tau, pg/ml | 464 [324;618] |
P-tau, pg/ml | 73.4 [52.3;94.4] |
Genetic risk | |
ApoEε4 + | 60 (53.1%) |
Sleep parameters | |
Questionnaire | |
Epworth sleepiness scale | 5.00 [3.00;8.00] |
Polysomnography | |
Total sleep time, hours | 4.57 [3.51;5.38] |
Sleep efficiency, % | 68.0 [53.7;78.2] |
N1, % | 12.1 [8.14;18.4] |
N2, % | 24.3 (11.3) |
SWS, % | 17.2 [8.27;24.5] |
REM sleep, % | 6.74 [2.48;11.2] |
Latency to N1, minutes | 21.0 [9.26;41.8] |
Latency to REM, minutes | 161 [99.6;250] |
AHI | 25.9 [15.1;48.5] |